相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Molecular Characterization of Peritoneal Mesotheliomas
Michael Offin et al.
JOURNAL OF THORACIC ONCOLOGY (2022)
The Updating of Biological Functions of Methyltransferase SETDB1 and Its Relevance in Lung Cancer and Mesothelioma
Li Yuan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
AXL Inactivation Inhibits Mesothelioma Growth and Migration via Regulation of p53 Expression
Wei Song et al.
CANCERS (2020)
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy
Michele Carbone et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Genetic predisposition for malignant mesothelioma: A concise review
Marta Betti et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2019)
Cyclin D1 is a mediator of gastrointestinal stromal tumor KIT-independence
Wen-Bin Ou et al.
ONCOGENE (2019)
Building a Bridge between Chemotherapy and Immunotherapy in Malignant Pleural Mesothelioma: Investigating the Effect of Chemotherapy on Immune Checkpoint Expression
Elly Marcq et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Integrative Molecular Characterization of Malignant Pleural Mesothelioma
Jutija Hmeljaki et al.
CANCER DISCOVERY (2018)
Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal Tumors
Weicai Chen et al.
CANCER RESEARCH (2017)
Prognostic value of ERCC1, RRM1, BRCA1 and SETDB1 in early stage of non-small cell lung cancer
A. Lafuente-Sanchis et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
Co-targeting of FAK and MDM2 triggers additive anti-proliferative effects in mesothelioma via a coordinated reactivation of p53
Wen-Bin Ou et al.
BRITISH JOURNAL OF CANCER (2016)
Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
Raphael Bueno et al.
NATURE GENETICS (2016)
High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma
Yoshie Yoshikawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Whole exome and targeted deep sequencing identify genome-wide allelic loss and frequent SETDB1 mutations in malignant pleural mesotheliomas
Hio Chung Kang et al.
ONCOTARGET (2016)
Setdb1, a novel interactor of ΔNp63, is involved in breast tumorigenesis
Carla Regina et al.
ONCOTARGET (2016)
Setdb1 Is Required for Myogenic Differentiation of C2C12 Myoblast Cells via Maintenance of MyoD Expression
Young Joon Song et al.
MOLECULES AND CELLS (2015)
Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden
Bengt Jarvholm et al.
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2015)
Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53
Qi Fei et al.
NATURE COMMUNICATIONS (2015)
Whole-Exome Sequencing Reveals Frequent Genetic Alterations in BAP1, NF2, CDKN2A, and CUL1 in Malignant Pleural Mesothelioma
Guangwu Guo et al.
CANCER RESEARCH (2015)
SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway
Qiao-Yang Sun et al.
JOURNAL OF PATHOLOGY (2015)
Histone methyltransferase SETDB1 is required for prostate cancer cell proliferation, migration and invasion
Yi Sun et al.
ASIAN JOURNAL OF ANDROLOGY (2014)
p53 Down-regulates SETDB1 gene expression during paclitaxel induced-cell death
Hee-Jung Noh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Multipoint targeting of the PI3K/mTOR pathway in mesothelioma
S. Zhou et al.
BRITISH JOURNAL OF CANCER (2014)
The Mbd1-Atf7ip-Setdb1 pathway contributes to the maintenance of X chromosome inactivation
Alissa Minkovsky et al.
EPIGENETICS & CHROMATIN (2014)
ESET histone methyltransferase is essential to hypertrophic differentiation of growth plate chondrocytes and formation of epiphyseal plates
Liu Yang et al.
DEVELOPMENTAL BIOLOGY (2013)
ESET histone methyltransferase regulates osteoblastic differentiation of mesenchymal stem cells during postnatal bone development
Kevin A. Lawson et al.
FEBS LETTERS (2013)
Asbestos is not just asbestos: an unrecognised health hazard
Francine Baumann et al.
LANCET ONCOLOGY (2013)
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
Matthew Bott et al.
NATURE GENETICS (2011)
Germline BAP1 mutations predispose to malignant mesothelioma
Joseph R. Testa et al.
NATURE GENETICS (2011)
AXL regulates mesothelioma proliferation and invasiveness
W-B Ou et al.
ONCOGENE (2011)
Targeted Inhibition of Multiple Receptor Tyrosine Kinases in Mesothelioma
Wen-Bin Ou et al.
NEOPLASIA (2011)
Nearly identical near-haploid karyotype in a peritoneal mesothelioma and a retroperitoneal malignant peripheral nerve sheath tumor
William R. Sukov et al.
CANCER GENETICS AND CYTOGENETICS (2010)
Chromosomal deletion in patients with malignant pleural mesothelioma
S. Neragi-Miandoab et al.
Interactive Cardiovascular and Thoracic Surgery (2009)
Adult acute lymphoblastic leukemia with near haploidy, hyperdiploidy and Ph positive lines: a rare entity with poor prognosis
SK Sunil et al.
LEUKEMIA & LYMPHOMA (2006)
Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling
GJ Gordon et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins
DC Schultz et al.
GENES & DEVELOPMENT (2002)